These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8349603)

  • 1. Generation and characterization of a competitive antagonist of human hepatocyte growth factor, HGF/NK1.
    Lokker NA; Godowski PJ
    J Biol Chem; 1993 Aug; 268(23):17145-50. PubMed ID: 8349603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte growth factor (HGF)/NK1 is a naturally occurring HGF/scatter factor variant with partial agonist/antagonist activity.
    Cioce V; Csaky KG; Chan AM; Bottaro DP; Taylor WG; Jensen R; Aaronson SA; Rubin JS
    J Biol Chem; 1996 May; 271(22):13110-5. PubMed ID: 8662798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of the NK1 fragment of human hepatocyte growth factor at 2.0 A resolution.
    Ultsch M; Lokker NA; Godowski PJ; de Vos AM
    Structure; 1998 Nov; 6(11):1383-93. PubMed ID: 9817840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2.
    Schwall RH; Chang LY; Godowski PJ; Kahn DW; Hillan KJ; Bauer KD; Zioncheck TF
    J Cell Biol; 1996 May; 133(3):709-18. PubMed ID: 8636243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for agonism and antagonism of hepatocyte growth factor.
    Tolbert WD; Daugherty-Holtrop J; Gherardi E; Vande Woude G; Xu HE
    Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13264-9. PubMed ID: 20624990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor.
    Mizuno K; Inoue H; Hagiya M; Shimizu S; Nose T; Shimohigashi Y; Nakamura T
    J Biol Chem; 1994 Jan; 269(2):1131-6. PubMed ID: 8288571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of human hepatocyte growth factor mutants obtained by deletion of structural domains.
    Okigaki M; Komada M; Uehara Y; Miyazawa K; Kitamura N
    Biochemistry; 1992 Oct; 31(40):9555-61. PubMed ID: 1327117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK1, a natural splice variant of hepatocyte growth factor/scatter factor, is a partial agonist in vivo.
    Jakubczak JL; LaRochelle WJ; Merlino G
    Mol Cell Biol; 1998 Mar; 18(3):1275-83. PubMed ID: 9488442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential mitogenic effects of single chain hepatocyte growth factor (HGF)/scatter factor and HGF/NK1 following cleavage by factor Xa.
    Pediaditakis P; Monga SP; Mars WM; Michalopoulos GK
    J Biol Chem; 2002 Apr; 277(16):14109-15. PubMed ID: 11832492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by copper(II) binding of hepatocyte growth factor (HGF) interaction with its receptor Met and blockade of HGF/Met function.
    Wright TG; Tsai J; Jia Z; Elliott BE
    J Biol Chem; 2004 Jul; 279(31):32499-506. PubMed ID: 15161915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and Characterization of a Chinese Hamster Ovary Heparan Sulfate Cell Mutant Defective in Both Met Receptor Binding and Hepatocyte Growth Factor NK1/Met Signaling.
    Cao T; Pan J; Li X; He Y; Jiang Y; Chang Y; Zhang Q; Lan Y; Wang H; Jiao W; Tian Z; Zhang L
    Cell Physiol Biochem; 2018; 48(4):1480-1491. PubMed ID: 30107380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist.
    Tolbert WD; Daugherty J; Gao C; Xie Q; Miranti C; Gherardi E; Vande Woude G; Xu HE
    Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14592-7. PubMed ID: 17804794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and biophysical characterization of recombinant human hepatocyte growth factor isoforms produced in Escherichia coli.
    Stahl SJ; Wingfield PT; Kaufman JD; Pannell LK; Cioce V; Sakata H; Taylor WG; Rubin JS; Bottaro DP
    Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):763-72. PubMed ID: 9307026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding.
    Lokker NA; Mark MR; Luis EA; Bennett GL; Robbins KA; Baker JB; Godowski PJ
    EMBO J; 1992 Jul; 11(7):2503-10. PubMed ID: 1321034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of hepatocyte growth factor isoforms on epithelial and endothelial tubulogenesis.
    Montesano R; Soriano JV; Malinda KM; Ponce ML; Bafico A; Kleinman HK; Bottaro DP; Aaronson SA
    Cell Growth Differ; 1998 May; 9(5):355-65. PubMed ID: 9607557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor.
    Date K; Matsumoto K; Shimura H; Tanaka M; Nakamura T
    FEBS Lett; 1997 Dec; 420(1):1-6. PubMed ID: 9450538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
    Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis and molecular modeling of the N-terminal kringle-containing domain of hepatocyte growth factor identifies amino acid side chains important for interaction with the c-Met receptor.
    Lokker NA; Presta LG; Godowski PJ
    Protein Eng; 1994 Jul; 7(7):895-903. PubMed ID: 7971951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis.
    Hartmann G; Naldini L; Weidner KM; Sachs M; Vigna E; Comoglio PM; Birchmeier W
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11574-8. PubMed ID: 1280830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling.
    Sakata H; Stahl SJ; Taylor WG; Rosenberg JM; Sakaguchi K; Wingfield PT; Rubin JS
    J Biol Chem; 1997 Apr; 272(14):9457-63. PubMed ID: 9083085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.